Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
Farmers Insurance
Merck
McKinsey
McKesson
Colorcon
Chinese Patent Office
Accenture
QuintilesIMS

Generated: October 19, 2017

DrugPatentWatch Database Preview

M.V.I.-12 Drug Profile

« Back to Dashboard

Which patents cover M.v.i.-12, and when can generic versions of M.v.i.-12 launch?

M.v.i.-12 is a drug marketed by Hospira and Teligent Pharma Inc and is included in two NDAs.

The generic ingredient in M.V.I.-12 is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine; riboflavin 5'-phosphate sodium; thiamine; vitamin a; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine; riboflavin 5'-phosphate sodium; thiamine; vitamin a; vitamin e profile page.

Summary for Tradename: M.V.I.-12

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A','VITAMIN E') AND hsdb_drugname IS N' at line 1
US Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list75